Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$0.8 - $1.12 $19,980 - $27,972
-24,975 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$0.97 - $1.32 $6,852 - $9,324
7,064 Added 39.44%
24,975 $28,000
Q1 2021

May 14, 2021

BUY
$1.24 - $3.3 $22,209 - $59,106
17,911 New
17,911 $23,000

Others Institutions Holding SLNO

# of Institutions
1
Shares Held
550K
Call Options Held
0
Put Options Held
0

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $398M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.